Inventor
MORETTA ALESSANDRO
IT21 patents
⚠️ This page may combine multiple inventors who share the name “MORETTA ALESSANDRO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MORETTA ALESSANDRO
5 patentsUS8119775B2Feb 21, 2012
Human anti-KIR antibodies
MORETTA ALESSANDRO68 citations95
US8993319B2Mar 31, 2015
Monoclonal antibodies against NKG2A
MORETTA ALESSANDRO31 citations91
US8614307B2Dec 24, 2013
Nucleic acids encoding human anti-kir antibodies
MORETTA ALESSANDRO15 citations88
US9902936B2Feb 27, 2018
PAN-KIR2DL NK-receptor antibodies and their use in diagnostics and therapy
MORETTA ALESSANDRO9 citations82
US8465931B2Jun 18, 2013
Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor
MORETTA ALESSANDRO3 citations57
UNIV GENOVA
3 patentsUS7279291B2Oct 9, 2007
Polypeptides having a triggering NK activity and biological applications
UNIV GENOVA2 citations58
US7074409B2Jul 11, 2006
Polypeptides having a triggering NK activity and biological applications
UNIV GENOVA1 citations58
US7138243B2Nov 21, 2006
NTB-A, a surface molecule involved in natural killer cells activity
UNIV GENOVA1 citations47
INNATE PHARMA SAS
2 patentsUS6979546B2Dec 27, 2005
Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same
INNATE PHARMA SAS23 citations88
US7517966B2Apr 14, 2009
Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same
INNATE PHARMA SAS9 citations79